U.S. patent application number 17/465775 was filed with the patent office on 2022-05-12 for conduit for transseptal passage to the aorta.
This patent application is currently assigned to Synecor LLC. The applicant listed for this patent is Synecor LLC. Invention is credited to William L. Athas, Emer M. Feerick, Kevin Johnson, Matthew Moran, Richard Phelan, Richard S. Stack.
Application Number | 20220143387 17/465775 |
Document ID | / |
Family ID | |
Filed Date | 2022-05-12 |
United States Patent
Application |
20220143387 |
Kind Code |
A1 |
Stack; Richard S. ; et
al. |
May 12, 2022 |
Conduit for Transseptal Passage to the Aorta
Abstract
A conduit for creating a passage from a right atrium to a left
atrium, through a mitral valve into the left ventricle, and to
provide a passage from the left ventricle into the aortic valve.
The conduit includes an elongate tubular member having a shaft with
a proximal section and a distal loop section at a distal end of the
proximal section. The distal loop section includes a proximal
curve, a distal curve, a generally straight segment extending
between the curves, and a distal tip. The shaft in the distal loop
section curves back on itself so that proximal curve is formed by a
part of the shaft that is closer along the length of the shaft to
the distal tip. The shapes of the proximal and distal curves are
selected to direct the distal tip into the mitral valve after it
has crossed the inter-atrial septum from the right atrium to the
left atrium of the heart, and to orient the distal opening of the
distal tip towards the aortic valve when the proximal curve is in
the mitral valve and the distal tip is in the left ventricle.
Inventors: |
Stack; Richard S.; (Chapel
Hill, US) ; Athas; William L.; (Chapel Hill, US)
; Johnson; Kevin; (Durham, US) ; Feerick; Emer
M.; (Galway, IE) ; Moran; Matthew; (Galway,
IE) ; Phelan; Richard; (Kilkenny, IE) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Synecor LLC |
Durham |
NC |
US |
|
|
Assignee: |
Synecor LLC
Durham
NC
|
Appl. No.: |
17/465775 |
Filed: |
September 2, 2021 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
16578374 |
Sep 22, 2019 |
11135421 |
|
|
17465775 |
|
|
|
|
62802212 |
Feb 7, 2019 |
|
|
|
International
Class: |
A61M 60/857 20060101
A61M060/857; A61B 17/34 20060101 A61B017/34; A61F 2/24 20060101
A61F002/24; A61M 25/09 20060101 A61M025/09; A61M 60/135 20060101
A61M060/135; A61M 60/148 20060101 A61M060/148 |
Claims
1. A conduit for creating a passage from a right atrium to a left
atrium, through a mitral valve into the left ventricle, the conduit
comprising: an elongate tubular member having a main body with a
proximal portion and a distal portion distal to the proximal
portion, the distal portion including a distal loop section having
a proximal curve, a distal curve, a generally straight segment
extending between the proximal and distal curves, and a distal tip,
wherein the distal loop section curves back on itself, wherein the
distal portion is formed using a blend of 40D and 55D durometer
polymeric material along its length, the proximal portion is formed
of a polymeric material having greater stiffness than the distal
portion.
2. The conduit of claim 1, wherein the proximal and distal curves
have shapes selected to direct the distal tip into a mitral valve
after it has crossed an inter-atrial septum from a right atrium to
a left atrium of a heart, and to orient a distal opening of the
distal tip towards an aortic valve of the heart when the straight
segment or the distal curve is in the mitral valve and the distal
tip is in a left ventricle.
3. The conduit of claim 1, wherein a widest lateral dimension of
the distal curve taken in a direction perpendicular to a
longitudinal axis of the main body is smaller than a widest lateral
dimension of the proximal curve taken in a direction perpendicular
to the longitudinal axis of the main body of the conduit.
4. The conduit of claim 1, wherein a widest lateral dimension of
the distal curve taken in a direction perpendicular to a
longitudinal axis of the main body is approximately equal to a
widest lateral dimension of the proximal curve taken in a direction
perpendicular to the longitudinal axis of the main body of the
conduit.
5. The conduit of claim 1, wherein lengths of radii of the distal
and proximal curves, a length of the generally straight segment
along a longitudinal axis of said generally straight segment, a
widest lateral dimension of the distal loop section taken in a
direction perpendicular to a longitudinal axis of the main body of
the conduit, and a longitudinal length L of the distal loop section
taken in a direction parallel to a longitudinal axis of the main
body are proportioned so that when the proximal curve is within
mitral valve, the distal curve seats near a left ventricular apex
and the distal tip is oriented towards, and in close proximity to,
an aortic valve.
6. The conduit of claim 1, wherein the generally straight segment
has a length selected to cause the distal curve to be positioned
near a left ventricular apex and the distal tip to be positioned in
close proximity to an aortic valve when the proximal curve is
within a mitral valve.
7. The conduit of claim 1, wherein the distal loop section is a
generally enclosed loop.
8. The conduit of claim 5, wherein the distal tip is enclosed
within the distal loop section, bounded by the distal and proximal
curves, the generally straight segment, and a part of the main body
that is proximal to the proximal curve.
9. The conduit of claim 1, wherein the main body has a generally
straight section proximal to the distal loop section and wherein an
edge of the proximal curve passes closely adjacent to said
generally straight section so that said generally straight section
of the main body extends tangentially with respect to the proximal
curve.
10. The conduit of claim 1, wherein the distal curve has smaller
radius than the proximal curve, so that the distal loop section has
a width that tapers from a distal to a proximal direction.
11. The conduit of claim 1, wherein the conduit includes a second
generally straight section on which the distal tip is
positioned.
12. The conduit of claim 9, wherein the second generally straight
section orients the distal tip away from the main body.
13. The conduit of claim 1, wherein the elongate member has a
longitudinal axis that includes a distal curve portion extending
through the distal curve and a proximal curve portion extending
through the proximal curve, and wherein the elongate member is
shape set such that the distal curve portion of the longitudinal
axis and the proximal curve portion of the longitudinal axis lie in
a common plane.
14. The conduit of claim 1, wherein the elongate member has a
longitudinal axis that includes a distal curve portion extending
through the distal curve and a proximal curve portion extending
through the proximal curve, and wherein the elongate member is
shape set such that the distal curve portion of the longitudinal
axis and the proximal curve portion of the longitudinal axis lie in
different planes.
15. The conduit of claim 1, wherein the proximal portion of the
elongate member is formed using a polymeric material of 72D
durometer, and the elongate member includes an intermediate portion
distally adjacent to the proximal portion formed using a polymeric
material of durometer of 55D.
16. The conduit of claim 1 wherein a ratio of 40D material and 55D
material in the distal portion is 50:50.
17. The conduit of claim 1, wherein the distal tip is formed of
lower durometer material than the distal loop section.
18. The conduit of claim 15, wherein the proximal portion has a
length of at least 450 mm, and the intermediate portion has a
length of at least 485 mm.
Description
[0001] This application is a continuation of U.S. application Ser.
No. 16/578,374, filed Sep. 22, 2019, which claims the benefit of
U.S. Provisional Application No. 62/802,212, filed Feb. 7, 2019.
Each of the foregoing applications is incorporated hereby
reference.
BACKGROUND
[0002] Various medical procedures in use today involve passage of
devices from the right side of the heart to the left side across
the inter-atrial septum in a well-established technique known as
transseptal catheterization.
[0003] Commonly owned application Ser. No. 16,578,375, Systems and
Methods for Transseptal Delivery of Percutaneous Ventricular Assist
Devices and Other Non-Guidewire Based Transvascular Therapeutic
Devices, filed Sep. 22, 2019, now U.S. Pat. No. 11,065,438, which
is incorporated herein by reference, discloses a system and method
for delivering therapeutic devices positionable at the aortic
valve, and gives as a primary example its use to deliver pVADs. In
that application, transseptal catheterization is used to deliver a
long flexible cable such that it extends from the venous
vasculature through the heart to the arterial vasculature. Once
positioned the cable has one end extending from the right
subclavian vein and an opposite end extending from the right or
left femoral artery. Once positioned in this way, a grasper is
attached to the cable at the femoral artery, and the cable is
withdrawn from the right subclavian vein to position the grasper
along the route previously occupied by the cable. The grasper is
then attached at the right subclavian vein to a pVAD and pulled
from the femoral artery while the pVAD is simultaneously pushed at
the right subclavian vein. This combination of pulling and pushing
force moves the pVAD into the heart, across the septum and the
mitral valves, and into its final position at the aortic valve.
[0004] Commonly owned co-pending application PCT/US2017/62913,
filed Nov. 22, 2017, published as WO/2018/098210 (incorporated
herein by reference) discloses a system and method for delivering
mitral valve therapeutic devices to the heart (such as devices for
positioning a replacement mitral valve or devices for treating a
native mitral valve) using a transseptal approach. In that
application, transseptal catheterization is used to position a
cable that is used to deliver a therapeutic device to the mitral
valve site. Once the cable is positioned it has one end extending
from the right femoral vein and an opposite end extending from the
left or right femoral artery. The mitral valve therapeutic device
is attached to the cable at the right femoral vein. The cable is
then pulled at the femoral artery while the mitral valve
therapeutic device is simultaneously pushed at the right femoral
vein. This combination of pulling and pushing force moves the
mitral valve therapeutic device into the heart, across the septum
and to its final position at the mitral valve.
[0005] In each of the above procedures, the step of pulling the
cable and the grasper are carried out with those devices extending
through a protective device (referred to in those applications as a
left ventricle redirector "LVR")) having the features described in
those applications. This avoids disruption of the valve structures
when tension is applied to the grasper or cable.
[0006] In each of the above procedures, a Brockenbrough type of
transseptal catheterization is initially performed using access
from the right femoral vein, and then other devices make use of the
transseptal access created to aid in positioning of the wire or
cable that is to ultimately reach the aorta and femoral artery. A
common challenge of these procedures is the need to provide safe
passage for such devices downwardly within the left atrium from the
transseptal puncture site towards the mitral valve, and then
through the mitral valve and upwardly within the left ventricle to
the aortic valve, without engaging the delicate chordae tendineae
of the mitral valve, and then into the aorta beyond the level of
the coronary sinuses to the aortic arch and descending aorta. This
application describes a right to left conduit (RLC) configured to
navigate this passage, while possessing material properties that
resist kinking and transmit the torque needed to achieve delivery
with minimal impact to the chordae or endocardial tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
[0007] FIG. 1 is a side elevation view of a Right-to-Left conduit
("RLC").
[0008] FIG. 2A is a side elevation view of the distal part of the
RLC.
[0009] FIG. 2B is a partially cut-away view of the region of the
RLC encircled in FIG. 2A.
[0010] FIG. 2C is a side elevation view similar to FIG. 2A, but
showing an alternative configuration in which the widest lateral
dimension of the distal curve is approximately equal to the widest
lateral dimension of the proximal curve.
[0011] FIG. 2D is a side elevation view taken ninety degrees from
the view of FIG. 2A.
[0012] FIG. 2E is similar to FIG. 2D, but shows an alternative
embodiment in which the longitudinal axes of the shaft in the
proximal and distal curves lie in different planes.--
[0013] FIGS. 3A through 6 are a series of figures schematically
illustrating steps in which the RLC is used to help deliver a cable
device that is to be passed through the heart between the venous
and arterial vasculature, in which:
[0014] FIG. 3A illustrates transseptal advancement of a wire
through a Brockenbrough transseptal catheter and into the left
atrium.
[0015] FIG. 3B illustrates positioning of the RLC after its distal
tip has passed through the mitral valve into the left
ventricle.
[0016] FIG. 4 illustrates the position of the RLC in the left
ventricle oriented towards the aortic valve. The arrows in FIG. 4
represent the "windshield wiper" motion of the distal tip of the
RLC after it passes through the mitral valve but before the wire is
advanced through it into the aortic valve.
[0017] FIG. 5 illustrates the steps of using a balloon catheter for
an atrial septostomy and then to confirm that the path traversed by
the wire is free from chordae entrapment.
[0018] FIG. 6 illustrates the step of advancing a snare over the
RLC in preparation for use of the snare to capture and retrieve the
end of a cable advanced through the RLC.
DETAILED DESCRIPTION
[0019] Referring to FIG. 1 the Right-to-Left conduit 100 ("RLC") is
an elongate tubular catheter having a length sufficient to permit
it to extend from the RFV of a human adult to the right atrium,
across the interatrial septum (via a trans-septal puncture) to the
left atrium, through the mitral valve, left ventricle, aortic valve
to the aortic arch, and then to the descending aorta. In a
preferred embodiment, this length exceeds 150 cm, and it may be 160
cm or longer. A lumen extends through the RLC 100 from a proximal
port 102 to an opening at the distal end. A flush port is also
fluidly connected with the lumen of the RLC as shown.
[0020] The RLC has a distal portion 104, an intermediate portion
106, and a proximal portion 108. The proximal and intermediate
portions, 108, 106 and much of the distal portion 104, are of
generally straight tubular construction. These parts of the shaft
may be collectively referred to as the main body of the shaft. The
distal portion 104 includes a distal loop 110 that has been shape
set. The shape of the loop helps the distal end of the RCL pass
into the mitral valve after it has crossed the inter-atrial septum
from the right to the left side of the heart, further aids in
orienting the distal opening of the RLC towards the aortic valve
(as will be discussed in connection with FIG. 4) when the distal
part of the RLC is in the left ventricle.
[0021] More particularly, the distal loop 110 includes a distal
(where for the purposes of this description of the curves of the
RLC the term "distal" and "proximal" are used in regard to the
entire length of the catheter) curve in regard to the entire length
of the catheter 112, a more proximal curve 114, a generally
straight segment 116 extending between the curves, and a distal tip
118. The RLC is shape set with the longitudinal axes of the distal
and proximal curves in a common plane as shown in FIG. 2D, although
in alternative embodiments such as the embodiment shown in FIG. 2E
they might lie in different planes. In other embodiments, one or
both of the curves might be formed with a shape where the
longitudinal axis forms a three-dimensional shape and thus does not
lie within a single plane. The generally straight segment 116 may
be straight or it may be curved with a very large radius of
curvature to produce a significantly more gradual curve than the
proximal and distal curves.
[0022] The curves 112, 114 are arranged to cause the distal loop
110 to curve back on itself, so that the distal curve 112 is formed
by a part of the RLC shaft that is closer along the length of the
shaft to the distal tip 118 than is the proximal curve 114. The
radius of the distal curve is smaller than that of the proximal
curve, so that the lateral width (perpendicular to the longitudinal
axis of the straight section of the shaft) of the loop 110 tapers
inwardly from a proximal to distal direction. The distal tip is
preferably enclosed within the loop, bounded by distal and proximal
curves, segment 116, and the main body of the shaft. It is also,
preferably, oriented with its distal opening facing away from the
main body of the shaft.
[0023] Referring to FIG. 2A, the radii of the distal and proximal
curves, the length of the generally straight segment 116 along its
longitudinal axis, the widest lateral dimension W of the distal
loop (measured in a direction perpendicular to the longitudinal
axis of the straight part of the RLC), and the longitudinal length
L of the distal loop (in a direction parallel to the longitudinal
axis of the straight part of the RLC) are proportioned so that when
the proximal curve 114 is within mitral valve, the distal curve 112
is positioned in the left ventricular outflow tract (as shown in
3B) and the tip 118 is oriented towards, and in close proximity to,
the aortic valve. In one embodiment, length L may be in the range
of 65-95 mm, with a preferred range of approximately 70-90 mm, or
more preferably approximately 75-85 mm. Width W may be in the range
of 35-65 mm, with a preferred range of approximately 40-60 mm, or
more preferably approximately 45-55 mm. The radius of the distal
curve 112 may be in the range of 5-35, with a preferred range of
10-30 mm, and a most preferred range of 15-25 mm. The radius of the
proximal curve 114 may be in the range of 10-40 mm, with a
preferred range of 15-35 mm, and a most preferred range of 20-30
mm.
[0024] In the embodiment that is shown in FIG. 2A, the widest
lateral dimension of the proximal curve 114, taken in a direction
perpendicular to the longitudinal axis of the main shaft of the
conduit, is wider than the widest lateral dimension of the distal
curve 112 taken in a direction perpendicular to the longitudinal
axis of the main shaft of the conduit. However, in other
embodiments these widths may be approximately equal (for example,
as shown in FIG. 2C) but the curvature would be ideally selected to
orient the distal tip 118 towards the interior of the loop, thus
ensuring that when the RLC is positioned with its distal tip in the
left ventricle, the tip is generally oriented towards the aorta as
shown in FIG. 3B.
[0025] The circumference of the curve 112 passes closely adjacent
to the straight section of the main body of the main shaft in
distal region 104, so that the main body extends tangentially with
respect to the circumference of the proximal curve 114. The
curvature of the proximal curve continues beyond this tangential
area, so that the distal tip 118 is disposed within a generally
enclosed loop as noted above. In other embodiments, the proximal
curve and/or the distal tip may cross the straight section of the
shaft.
[0026] The materials for the RLC are selected to give the conduit
sufficient column strength to be pushed through the vasculature,
torqued to orient its tip towards the aortic valve, and tracked
over a wire, and it should have properties that prevent the distal
loop 110 from permanently deforming as it is tracked over a wire.
Although the distal loop 110 is moved out of its pre-shaped loop
configuration to track over the wire, it is important that the
shape-setting of the curves be retained. Otherwise the performance
benefits of the distal loop's shape which, as evident from the
Method description below are to aid proper movement into and
through the mitral valve, to orient the tip of the RLC towards the
aortic valve, and to track over the wire all the way to the
descending aorta will not be realized.
[0027] Preferred material properties for the RLC will next be
given, although materials having different properties may be used
without departing from the scope of the invention. The shaft
includes an outer jacket formed suitable polymeric material (e.g.
polyether block amide, "PEBA," such as that sold under the brand
name Pebax). A wire braid extends through shaft portions 108, 106
and most of 104 to enhance the torqueability of the RLC. A
lubricious liner made using PTFE, ultra-high molecular weight
polyethylene (UHMWPE), or like material also extends through these
sections, allowing smooth relative movement between the RLC and the
wire and cable that pass through it. The braid and liner terminate
in the distal tip 118 as will be described with respect to FIG. 2B.
The liner, braid and outer jacket are preferably subjected to a
reflow process to create a composite material.
[0028] The most proximal portion 108 of the RLC, which may be
between 450 and 550 mm in length (most preferably between 485 and
525 mm), is preferably formed from a relatively stiff material made
from, as one example, 72D Pebax. Adjacent to the proximal portion
108 is the intermediate portion 106. This portion may have a length
greater than 485 mm, or more preferably between 500-600 mm (most
preferably between 530-570 mm), and it is preferably formed of
fairly stiff material, but one that is more flexible than that used
for the most proximal portion. As one example, this material may be
55D Pebax. These materials give the proximal and intermediate
portions 108, 106 sufficient column strength and torqueability
needed for its intended use.
[0029] Shaft section 104 is designed to be more flexible that the
more proximal sections, because it must be able to pass through the
heart during use. This section may be formed of a material such as
40D Pebax, although it is more preferably formed of a blend of 40D
and 55D Pebax. This avoids an abrupt transition at the junction
between sections 104 and 106 and can help to avoid kinking at that
junction. The ratio of 40D to 55D material in the blend may be
50:50 or an alternative ratio. Shaft section 104 makes up the most
distal part of the straight section of the main shaft, as well as
both the distal and proximal curves 112, 114. The length of shaft
section 104 is preferably between 510 and 610 mm, and more
preferably between 540 and 580 mm.
[0030] A preferred configuration for the distal tip 118 will next
be described. Referring to FIG. 2B, which is partially cut away to
show features below the outer extrusion, the distal tip 118
includes an atraumatic distalmost section 120 formed of soft 35D
Pebax or similarly soft material. Just proximal to the distal most
section is a more rigid section (e.g. 55D Pebax) 122, which
includes a radiopaque marker band 124 (e.g. Ptlr) and the
distal-most part of the lubricious liner 126. In the next most
proximal section 130 is the terminal portion of the braid 128,
which is covered by a more rigid material such as 72D polyethylene
or similar material. Each of the sections 120, 122, 130 is very
short in length, and preferably between 2-4 mm. As shown, the
distal tip is preferably a generally straight section of the RLC
extending from the distal curve 112.
[0031] It should be pointed out that while a number of preferred
features for the RLC have been described above, alternative
embodiments of the RLC might use any sub-combination of the
above-described features alone or with other features not described
here.
Method of Use
[0032] A method of placing the RLC via transseptal catheterization
will next be described. The purpose of RLC placement is to position
a conduit extending into a femoral vein and across the heart via
the interatrial septum, through the mitral valve into the left
ventricle, and then oriented towards the aortic valve. The RLC is
then advanced through the aortic valve, beyond the coronary sinuses
and through the ascending and descending aorta. In that position it
enables a user to deploy an arterio-venous cable in the descending
aorta that can be used to deliver other devices into the heart in
procedures such as those discussed in the Background section of
this application.
[0033] As an initial step, the practitioner obtains percutaneous
access to the vessels that are to be used for the intravascular
procedure. For the purposes of this discussion, it will be assumed
that access to the right and or left femoral artery (RFA, LFA), the
right or left femoral vein (RFV, LFV), and, if the procedure is one
involving advancement of devices from a superior location (as
discussed in the Background), the right subclavian vein (RSV) or
the left subclavian vein (LSV), or the right or left internal
jugular vein (RIJV, LIJV). One such sheath is shown in FIG. 3A,
positioned in the RSV.
[0034] A Brockenbrough transseptal catheter 132 (BTC) is introduced
through the RFV and, using the well-known technique of transseptal
catheterization, is passed from the right atrium (RA) into the left
atrium (LA). A wire 134, which may be an 0.035'' wire such as the
Abbott Versacore wire, is passed through the BTC and into the left
atrium (LA). See FIG. 3A.
[0035] The BTC 132 is withdrawn at the RFV and exchanged for the
RLC 100, which is advanced over the wire. The RLC preferably has
been filled with an 80/20 saline-contrast solution for additional
visibility under fluoroscopy. After it has crossed the inter-atrial
septum into the LA, the RLC is advanced toward the lateral edge of
the LA. From this position the wire is withdrawn proximally into
the RLC (away from the loop 110, labeled in FIGS. 1 and 2A). The
RLC is rotated counterclockwise about the axis of the main body
portion as the wire is slowly withdrawn. This causes the tip to
drop in an inferior direction into and through the mitral valve MV
towards the left ventricle LV. Once the tip is through the MV, the
RLC continues to be advanced, its shape causing the distal end of
the tip to move in a right-ward (the patient's right) and anterior
direction. This direction of motion is needed to orient the tip 118
towards the aortic valve AV, since the aortic valve is anterior and
to the right of the mitral valve. FIG. 3B shows the distal tip of
the RLC pointed towards the aortic valve. As shown, section 104 of
the RLC extends within the inferior vena cava (not shown), extends
through the inter-atrial septum S, drops into the mitral valve and
forward into the left ventricle. Note with regard to this drawing
that the distal curve 112 is positioned anterior (out of the plane
of the drawing towards the viewer) with respect to the proximal
curve.
[0036] The practitioner may, at this point, wish to verify that the
RLC tip is not trapped by the chordae tendineae CT of the mitral
valve. This may be done by observing the fluoroscopic image and
confirming the presence of a "windshield wiper" movement of the RLC
tip, as such movement suggests that the tip is not entangled in the
chordae. The arrows in FIG. 4 represent the "windshield wiper"
motion of the distal tip of the RLC. Although the wire is shown in
this drawing, the step of observing this motion of the distal tip
is ideally performed before the wire is re-extended from the
RLC.
[0037] When the distal tip 118 of the RLC 100 positioned in the LV,
its curvature directs its tip towards the aortic valve as shown in
FIG. 4. With the RCL positioned in this way, the guide wire 134 is
advanced through the aortic valve, around the aortic arch, and into
the descending aorta.
[0038] The RLC 100 is removed, leaving the wire 134 in place. A
balloon dilation catheter 136 is advanced over the wire 134 to
dilate the interatrial septum (atrial septostomy)--see balloon
position (1) in FIG. 5. A balloon that may be used for this purpose
is the 12.times.20 mm Boston Scientific Mustang balloon dilation
catheter or the tracker balloon described in co-pending application
Ser. No. 16,578,375 (U.S. Pat. No. 11,065,438). Following this, as
a second step, the inflated balloon catheter is advanced further
over the wire and through the mitral valve apparatus--see balloon
position (2) in FIG. 5--to the aortic valve to further confirm that
the wire path is free of the chordae entrapment.
[0039] The balloon catheter is removed and replaced over the wire
134 with the RLC 100, which is reintroduced and then advanced all
the way to the descending aorta as shown in FIG. 6.
[0040] A snare 138 is inserted in the RFA and used to capture the
wire 134 in the descending aorta. The subsequent steps from this
point may differ depending on the procedure that is to be
performed. The steps that will next be described assume that the
procedure involves placement of a cable to extend between the
venous and arterial vasculature as described in the Background
section, With the wire 134 loose in the snare, the snare is
advanced upward in the aorta and allowed to slide over the RLC 100
as shown in FIG. 6.
[0041] With the snare secured on the RLC, the wire is withdrawn
from the RFV and is exchanged for the cable (not shown) that is to
be used. The cable is advanced the full length of the RLC, which
remains in the position shown in FIG. 6. When the cable emerges
from the RLC in the descending aorta, the snare 134 is pulled off
the end of the RLC and used to capture the cable. The snare is
exteriorized from the RFA to draw the end of the cable that is
proximal to the RFA out the RFA. At this point both the cable and
RLC extend from the RFV to the RFA. The steps that happen next are
dependent on whether the end of the cable that is on the venous
side needs to be access from a superior site or a femoral site. If
a procedure to deliver a mitral valve therapeutic device, such as
that described in PCT application WO/2018/098210, is to be carried
out, the subsequent steps are performed using the cable extending
between the RFV and RFA. If a procedure to deliver a pVAD is to be
carried out, the cable may be exteriorized from the RSV using steps
described in Commonly owned application Ser. No. 16,578,375,
Systems and Methods for Transseptal Delivery of Percutaneous
Ventricular Assist Devices and Other Non-Guidewire Based
Transvascular Therapeutic Devices, (US Patent 11,065,438).
[0042] All patents and patent applications referred to herein,
including for purposes of priority, are fully incorporated herein
by reference.
* * * * *